Orient Technologies (NSE: ORIENTTECH) Q3 FY26 results: Why short-term margin pain may be the price of securing long-cycle government and services revenue
Read More 5 minute read Retail Industry News Dr. Martens (LSE: DOCS) shares plunge 12% as FY26 Q3 trading shows margin discipline at the cost of top-line softness Dr. Martens stock plunged 12% after Q3 FY26 results. Find out why the flat revenue outlook and DTC weakness are testing investor confidence. bySrinathJanuary 27, 2026